Pharmaceuticals in Mexico
Summary
Pharmaceuticals in Mexico industry profile provides top-line qualitative and quantitative summary information including: market size (value 2019-24, and forecast to 2029). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Key Highlights
Pharmaceuticals in Mexico industry profile provides top-line qualitative and quantitative summary information including: market size (value 2019-24, and forecast to 2029). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Key Highlights
- The pharmaceutical market includes sales of both prescriptions and over-the-counter (OTC) drugs. The market scope does not cover consumer healthcare and animal health products.
- The Mexican pharmaceuticals market recorded revenues of $13.6 billion in 2024, representing a compound annual growth rate (CAGR) of 7.0% between 2019 and 2024.
- The anti-infective drugs segment accounted for the market's largest proportion in 2024, with total revenues of $1.5 billion, equivalent to 11.0% of the market's overall value.
- The Mexican pharmaceuticals market witnessed healthy growth in 2024, registering an annual growth of 5.0%.
- Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the pharmaceuticals market in Mexico
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in Mexico
- Leading company profiles reveal details of key pharmaceuticals market players? global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the Mexico pharmaceuticals market with five year forecasts
- What was the size of the Mexico pharmaceuticals market by value in 2024?
- What will be the size of the Mexico pharmaceuticals market in 2029?
- What factors are affecting the strength of competition in the Mexico pharmaceuticals market?
- How has the market performed over the last five years?
- What are the main segments that make up Mexico's pharmaceuticals market?
1 EXECUTIVE SUMMARY
1.1. Market value
1.2. Market value forecast
1.3. Category segmentation
1.4. Geography segmentation
1.5. Market rivalry
1.6. Competitive landscape
2 MARKET OVERVIEW
2.1. Market definition
2.2. Market analysis
3 MARKET DATA
3.1. Market value
4 MARKET SEGMENTATION
4.1. Category segmentation
4.2. Geography segmentation
5 MARKET OUTLOOK
5.1. Market value forecast
6 FIVE FORCES ANALYSIS
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 COMPETITIVE LANDSCAPE
7.1. Who are the leading players?
7.2. What are the strengths of the leading players?
7.3. What are the recent developments in the market?
8 COMPANY PROFILES
8.1. Genomma Lab Internacional SAB de CV
8.2. Bayer AG
8.3. Sanofi
8.4. Boehringer Ingelheim International GmbH
9 MACROECONOMIC INDICATORS
9.1. Country data
10 APPENDIX
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine
1.1. Market value
1.2. Market value forecast
1.3. Category segmentation
1.4. Geography segmentation
1.5. Market rivalry
1.6. Competitive landscape
2 MARKET OVERVIEW
2.1. Market definition
2.2. Market analysis
3 MARKET DATA
3.1. Market value
4 MARKET SEGMENTATION
4.1. Category segmentation
4.2. Geography segmentation
5 MARKET OUTLOOK
5.1. Market value forecast
6 FIVE FORCES ANALYSIS
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 COMPETITIVE LANDSCAPE
7.1. Who are the leading players?
7.2. What are the strengths of the leading players?
7.3. What are the recent developments in the market?
8 COMPANY PROFILES
8.1. Genomma Lab Internacional SAB de CV
8.2. Bayer AG
8.3. Sanofi
8.4. Boehringer Ingelheim International GmbH
9 MACROECONOMIC INDICATORS
9.1. Country data
10 APPENDIX
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine
LIST OF TABLES
Table 1: Mexico pharmaceuticals market value: $ million, 2019-24
Table 2: Mexico pharmaceuticals market category segmentation: % share, by value, 2019-24
Table 3: Mexico pharmaceuticals market category segmentation: $ million, 2019-24
Table 4: Mexico pharmaceuticals market geography segmentation: $ million, 2024
Table 5: Mexico pharmaceuticals market value forecast: $ million, 2024-29
Table 6: Genomma Lab Internacional SAB de CV: Key Facts
Table 7: Genomma Lab Internacional SAB de CV: Annual Financial Ratios
Table 8: Genomma Lab Internacional SAB de CV: Key Employees
Table 9: Bayer AG: Key Facts
Table 10: Bayer AG: Annual Financial Ratios
Table 11: Bayer AG: Key Employees
Table 12: Bayer AG: Key Employees Continued
Table 13: Bayer AG: Key Employees Continued
Table 14: Sanofi: Key Facts
Table 15: Sanofi: Annual Financial Ratios
Table 16: Sanofi: Key Employees
Table 17: Sanofi: Key Employees Continued
Table 18: Boehringer Ingelheim International GmbH: Key Facts
Table 19: Boehringer Ingelheim International GmbH: Key Employees
Table 20: Mexico Size of Population (Million), 2020-24
Table 21: Mexico Real GDP (Constant 2010 Prices, $ Billion), 2020-24
Table 22: Mexico GDP (Current Prices, $ Billion), 2020-24
Table 23: Mexico Inflation, 2020-24
Table 24: Mexico Consumer Price Index (Absolute), 2020-24
Table 25: Mexico Exchange Rate, 2019-24
Table 1: Mexico pharmaceuticals market value: $ million, 2019-24
Table 2: Mexico pharmaceuticals market category segmentation: % share, by value, 2019-24
Table 3: Mexico pharmaceuticals market category segmentation: $ million, 2019-24
Table 4: Mexico pharmaceuticals market geography segmentation: $ million, 2024
Table 5: Mexico pharmaceuticals market value forecast: $ million, 2024-29
Table 6: Genomma Lab Internacional SAB de CV: Key Facts
Table 7: Genomma Lab Internacional SAB de CV: Annual Financial Ratios
Table 8: Genomma Lab Internacional SAB de CV: Key Employees
Table 9: Bayer AG: Key Facts
Table 10: Bayer AG: Annual Financial Ratios
Table 11: Bayer AG: Key Employees
Table 12: Bayer AG: Key Employees Continued
Table 13: Bayer AG: Key Employees Continued
Table 14: Sanofi: Key Facts
Table 15: Sanofi: Annual Financial Ratios
Table 16: Sanofi: Key Employees
Table 17: Sanofi: Key Employees Continued
Table 18: Boehringer Ingelheim International GmbH: Key Facts
Table 19: Boehringer Ingelheim International GmbH: Key Employees
Table 20: Mexico Size of Population (Million), 2020-24
Table 21: Mexico Real GDP (Constant 2010 Prices, $ Billion), 2020-24
Table 22: Mexico GDP (Current Prices, $ Billion), 2020-24
Table 23: Mexico Inflation, 2020-24
Table 24: Mexico Consumer Price Index (Absolute), 2020-24
Table 25: Mexico Exchange Rate, 2019-24
LIST OF FIGURES
Figure 1: Mexico pharmaceuticals market value: $ million, 2019-24
Figure 2: Mexico pharmaceuticals market category segmentation: $ million, 2019-24
Figure 3: Mexico pharmaceuticals market geography segmentation: % share, by value, 2024
Figure 4: Mexico pharmaceuticals market value forecast: $ million, 2024-29
Figure 5: Forces driving competition in the pharmaceuticals market in Mexico, 2024
Figure 6: Drivers of buyer power in the pharmaceuticals market in Mexico, 2024
Figure 7: Drivers of supplier power in the pharmaceuticals market in Mexico, 2024
Figure 8: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Mexico, 2024
Figure 9: Factors influencing the threat of substitutes in the pharmaceuticals market in Mexico, 2024
Figure 10: Drivers of degree of rivalry in the pharmaceuticals market in Mexico, 2024
Figure 1: Mexico pharmaceuticals market value: $ million, 2019-24
Figure 2: Mexico pharmaceuticals market category segmentation: $ million, 2019-24
Figure 3: Mexico pharmaceuticals market geography segmentation: % share, by value, 2024
Figure 4: Mexico pharmaceuticals market value forecast: $ million, 2024-29
Figure 5: Forces driving competition in the pharmaceuticals market in Mexico, 2024
Figure 6: Drivers of buyer power in the pharmaceuticals market in Mexico, 2024
Figure 7: Drivers of supplier power in the pharmaceuticals market in Mexico, 2024
Figure 8: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Mexico, 2024
Figure 9: Factors influencing the threat of substitutes in the pharmaceuticals market in Mexico, 2024
Figure 10: Drivers of degree of rivalry in the pharmaceuticals market in Mexico, 2024
